Cell and gene therapy manufacturing services market growth outlook through 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Cell & Gene Therapy Manufacturing Services Market Between 2026 And 2030?
The market for cell & gene therapy manufacturing services has experienced substantial growth in recent years. It is projected to escalate from $9.44 billion in 2025 to $11.08 billion in 2026, achieving a compound annual growth rate (CAGR) of 17.4%. This historical growth can be linked to an escalating number of cell and gene therapy clinical candidates, the early outsourcing of manufacturing services, the expansion of academic translational research, restricted in-house manufacturing capabilities, and an increasing need for specialized bioprocessing.
The cell & gene therapy manufacturing services market size is projected to experience swift expansion over the coming years. This market is anticipated to reach a valuation of $21.05 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.4%. The impetus for this growth in the forecast period stems from the escalating commercialization of cell and gene therapies, a rising need for large-scale manufacturing solutions, the expansion of personalized medicine pipelines, enhanced regulatory clarity for advanced therapies, and increased investments in advanced therapy infrastructure. Prominent trends identified for the forecast period include the amplification of GMP-compliant manufacturing capacity, the increasing adoption of automated cell processing systems, a growing requirement for scalable viral vector production, the expanded integration of advanced quality control technologies, and a heightened emphasis on manufacturing standardization.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Key Drivers Are Affecting The Cell & Gene Therapy Manufacturing Services Market Development?
The increasing occurrence of cancer and other target diseases is anticipated to boost the expansion of the cell and gene therapy manufacturing services market in the future. Cancer is a serious condition characterized by the rapid and uncontrolled proliferation of cells within the body, leading to atypical formations. As cancer cases rise, cell and gene therapies are emerging as hopeful new approaches to tackle the disease, thereby fueling the need for innovative and effective therapeutic options. For example, the American Cancer Society, a US-based nonprofit cancer advocacy organization, reported in February 2025 that an estimated 316,950 new instances of invasive breast cancer are projected for women and 2,800 for men in the US in 2025. Consequently, the elevated frequency of cancer and other relevant diseases is propelling the growth of the cell and gene therapy manufacturing services market moving ahead.
Which Segment Classifications Are Used In The Cell & Gene Therapy Manufacturing Services Market Segment Analysis?
The cell & gene therapy manufacturing services market covered in this report is segmented –
1) By Type: Gene Therapy, Cell Therapy
2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases
3) By Application: Commercial Manufacturing, Clinical Manufacturing
4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services
2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services
What Trends Are Transforming The Cell & Gene Therapy Manufacturing Services Market?
Major companies operating in the cell and gene therapy manufacturing services market are concentrating on developing innovative biomanufacturing technologies to improve the scalability, production efficiency, and overall quality of cell and gene therapies. For instance, in September 2025, ARPA-H, a US-based government health agency, launched a program to stimulate innovative biomanufacturing for cell and gene therapies. The program’s objective is to accelerate the advancement of sophisticated manufacturing platforms, enhance production yields, and enable cost-effective, scalable manufacturing of complex cell and gene therapy products. By supporting high-risk, high-reward technologies, this initiative is projected to drive innovation in biomanufacturing, fortify the manufacturing ecosystem, and facilitate quicker patient access to transformative therapies.
Which Firms Are Contributing To The Cell & Gene Therapy Manufacturing Services Market Ecosystem?
Major companies operating in the cell & gene therapy manufacturing services market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Fujifilm Holdings Corporation, Oxford Biomedica plc, Cell and Gene Therapy Catapult, Samsung Biologics Co. Ltd., BioNTech SE, Novartis International AG, Pfizer Inc., Boehringer Ingelheim International GmbH, Sarepta Therapeutics Inc., bluebird bio Inc., Precision BioSciences Inc., GSK plc, AstraZeneca plc, Bayer AG
Get The Full Cell & Gene Therapy Manufacturing Services Market Report:
Which Region Has The Greatest Market Share In The Cell & Gene Therapy Manufacturing Services Market?
North America was the largest region in the cell and gene therapy manufacturing services market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in the cell & gene therapy manufacturing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Cell & Gene Therapy Manufacturing Services Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Cell & Gene Therapy Manufacturing Services Market 2026, By The Business Research Company
Cell And Gene Therapy Contract Development And Manufacturing Organization Cdmo Market Report 2026
Cell And Gene Therapy Supply Chain Or Logistics Market Report 2026
Cell And Gene Therapy Clinical Trial Services Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
